Blood Journals Portfolio/LinkedIn
Sep 8, 2025, 03:48
Blood Podcast Alert: Voxelotor Drops, Pediatric SCD, Thrombosis in VEXAS Syndrome and TKIs in ALL
Blood Journals Portfolio shared on LinkedIn:
”September is Sickle Cell Disease Awareness Month and together we are working to conquer SCD!
Effects of voxelotor on cerebral blood flow in pediatric sickle cell disease; thrombosis in Vexas syndrome; response to tyrosine kinase inhibitors in ABL-class acute lymphoblastic leukemia describes how voxelotor is raising hemoglobin.
Highlights are:
- Kids + sickle cell + voxelotor: Imagine your kid’s brain saying “thanks” while your hemoglobin goes up, up, up. Voxelotor drops cerebral blood flow and oxygen extraction to more normal levels—like a spa retreat for tiny brains in crisis.
- VEXAS syndrome, meet your match: Thrombosis stages its dramatic entrance—because immune dashboards love throwing plot twists.
- ABL-class ALL hitting back: Tyrosine kinase inhibitors show they still remember their moves—clocking responses like a perfect encore.
Listen to the full episode here.”
Stay tuned for the podcast series in hematology with Hemostasis Today.
-
Sep 27, 2026, 04:5310 Posts Not to Miss This Week
-
Sep 27, 2026, 03:23Massimo Martino: VEN-DEC-GITMO – Advancing AML Treatment in Older Patients
-
Sep 27, 2026, 03:08Arrigo Francesco Giuseppe Cicero: Why Earlier LDL-C Lowering May Matter in Cardiovascular Prevention
-
Sep 27, 2026, 02:51Veronique Witko-Sarsat: Thromboinflammation at the 17th World Congress of Inflammation
-
Sep 27, 2026, 01:45Jin-Xiong She: Functional Iron Deficiency in the Setting of Chronic Inflammation
-
Sep 27, 2026, 01:44Crystal Karakochuk: Scientific Reports Launches New Collection on Iron Deficiency and Anemia
-
Sep 27, 2026, 01:44Arielle Nylander: National Expertise at the Center of Maternal Anemia Action
-
Sep 27, 2026, 01:43Muhammad Ans: Emerging Trends and Disparities in PE-Related Mortality Among Patients With AF
-
Sep 26, 2026, 18:01Kalyan Roy: Blood Group Chimerism as a Rare Cause of ABO Discrepancy